Calcineurin inhibitors revisited: A new paradigm for COVID-19?

The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) can cause mild, moderate or severe disease (COVID-19). In severe disease, there is hyperinflammation causing severe symptoms. Severe COVID-19 is an immunological phenomenon, rather than a direct viral damage disease. Therapies for COVI...

Descripción completa

Detalles Bibliográficos
Autores principales: Hage, René, Steinack, Carolin, Schuurmans, Macé M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7320855/
https://www.ncbi.nlm.nih.gov/pubmed/32603679
http://dx.doi.org/10.1016/j.bjid.2020.06.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7320855/
https://www.ncbi.nlm.nih.gov/pubmed/32603679
http://dx.doi.org/10.1016/j.bjid.2020.06.005

Ejemplares similares